NASDAQ: PBLSParabilis Medicines Inc Stock Ownership - Who owns Parabilis Medicines?
Insider buying vs selling
Have Parabilis Medicines Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ra Capital Management LP | Director | 2026-07-22 | 47,250 | $29.77 | $1.41MBuy |
| Ra Capital Management LP | Director | 2026-07-21 | 37,723 | $30.00 | $1.13MBuy |
| Ra Capital Management LP | Director | 2026-07-21 | 6,504 | $29.17 | $189.72kBuy |
| Ra Capital Management LP | Director | 2026-07-21 | 21,696 | $27.96 | $606.62kBuy |
| Ra Capital Management LP | Director | 2026-07-20 | 32,987 | $27.72 | $914.40kBuy |
| Ra Capital Management LP | Director | 2026-07-20 | 98,433 | $27.13 | $2.67MBuy |
| Alan Sebulsky | Director | 2026-06-15 | 4,065 | $27.10 | $110.15kBuy |
| Alan Sebulsky | Director | 2026-06-15 | 5,000 | $26.00 | $129.99kBuy |
| Alan Sebulsky | Director | 2026-06-12 | 8,435 | $27.67 | $233.40kBuy |
| Guy Levy | 10% Owner | 2026-06-11 | 527,070 | $9.48 | $5.00MBuy |
PBLS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PBLS insiders and whales buy or sell their stock.
PBLS Shareholders
What type of owners hold Parabilis Medicines Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 4.29% | 5,296,556 | $210.64M | Insider |
| James E. Flynn | 1.52% | 1,880,704 | $74.80M | Insider |
| Guy Levy | 0.43% | 527,070 | $20.96M | Insider |
| Alexis Borisy | 0.09% | 105,414 | $4.19M | Insider |
| Alan Sebulsky | 0.02% | 30,000 | $1.19M | Insider |
| Ra Capital Management LP | 0.02% | 28,933 | $1.15M | Institution |
| Racapi | 0.02% | 28,933 | $1.15M | Institution |
| Edward M. Fitzgerald | 0.01% | 14,688 | $584.14k | Insider |
| Fmr LLC | 0.01% | 10,293 | $409.35k | Institution |
| Fidlty | 0.01% | 10,293 | $409.35k | Institution |
PBLS vs Biotech Stocks
Parabilis Medicines Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.